Related Experiment Videos
Hypersensitivity pneumonitis associated with leflunomide therapy
Neil Martin1, J Alastair Innes, C Michael Lambert
1Western General Hospital and Edinburgh Royal Infirmary, Edinburgh, United Kingdom. nmartin@doctors.org.uk
The Journal of Rheumatology
|July 6, 2007
Summary
Disease modifying drugs for rheumatoid arthritis can cause lung problems. Even newer medications like leflunomide may lead to serious hypersensitivity pneumonitis, requiring careful use in at-risk patients.
Area of Science:
- Rheumatology
- Pulmonology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) management relies on disease-modifying drugs (DMARDs).
- Many DMARDs carry risks of toxic side effects, particularly pulmonary toxicity.
- Development of newer DMARDs aims to reduce pulmonary complications.
Observation:
- Even newer DMARDs can cause severe pulmonary toxicity.
- Hypersensitivity pneumonitis was observed following leflunomide initiation.
Findings:
- Leflunomide, a newer DMARD, is associated with potentially serious pulmonary toxicity.
- Hypersensitivity pneumonitis can occur even with medications designed for reduced pulmonary toxicity.
Implications:
- Caution is advised when prescribing leflunomide.
- Particular care is needed in patients with pre-existing pulmonary conditions or prior drug-induced lung issues.
- Risk-benefit assessment is crucial for leflunomide use in RA patients with pulmonary concerns.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...